4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-002350
Director sold 30,000 shares at an average $12.79 ($383,550)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-01-31 | Sale 10b5-1 | −25,000 | $12.23 | $305,750 | 876,283 | D |
| Harmon Cyrus Director | 2024-02-01 | Sale 10b5-1 | −5,000 | $15.56 | $77,800 | 871,283 | D |
| Open-market sales · 30,000 sh · avg $12.79 · $383,550 | |||||||
Loading xslF345X05/form4-02022024_050201.xml…